Jorge Lima: Amniotic Fluid Embolism and Its Impact on Maternal and Perinatal Outcomes
Jorge Lima, Assistant Guest Professor at NOVA Medical School, Gynecologist and Obstetrician at Hospital da Luz Lisbon, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Obstetrical and Gynecological Survey, adding:
“I am pleased to share our latest article:
‘Amniotic Fluid Embolism: A Silent Threat to Maternal Life—An Up-to-Date Comprehensive Review of the Pathophysiology, Diagnosis, and Outcome.’
Published in Obstetrical and Gynecological Survey, one of the leading review journals in Obstetrics and Gynecology, this article provides an up-to-date overview of amniotic fluid embolism (AFE), one of the most devastating and unpredictable obstetric emergencies.
Together with Oluwateniayo O. Okpaise, João Feldman de Pinho, Edna Kathleen Porter, and Rodrigo Ruano, we review current evidence on:
- Epidemiology and risk factors;
- Pathophysiological and immunological mechanisms;
- Diagnostic challenges and emerging biomarkers;
- Contemporary management strategies;
- Maternal and neonatal outcomes.
Although rare, AFE remains associated with substantial maternal and perinatal morbidity and mortality.
Improving awareness, facilitating early diagnosis, and optimizing multidisciplinary management are essential to improving outcomes.
I am grateful to my co-authors for this rewarding international collaboration (UK ,USA and Portugal) and for their commitment to advancing knowledge in maternal-fetal medicine.”
Title: Amniotic Fluid Embolism: A Silent Threat to Maternal Life— An Up-to-Date Comprehensive Review of the Pathophysiology, Diagnosis, and Outcome
Authors: Oluwateniayo O. Okpaise, Jorge Lima, João Feldman de Pinho, Edna Porter Kathleen, Rodrigo Ruano

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 7, 2026, 14:20Utsab Raj Panta: Navigating the A–E Classification in Acute Pulmonary Embolism
-
Jun 7, 2026, 14:19Ming Y Lim: The Burden and Impact of Bleeding in Newly Diagnosed Cancer Patients
-
Jun 7, 2026, 14:16What Would You Like to Know About Hemophilia Gene Therapy? – ISTH
-
Jun 7, 2026, 14:10Kamran Hajiyev: Reflections from The ICCA Stroke 2026
-
Jun 7, 2026, 14:08Faham Raza Jaffary: Beyond the Workplace – Driving Community Engagement and Empathy
-
Jun 7, 2026, 14:04Mayank Dwivedi: Transforming Outcomes Through Speed and Innovation In Stroke
-
Jun 7, 2026, 14:03Alejandro Gonzalez Veliz: What If Inflammation Is the Hidden Driver of Cardiovascular Disease?
-
Jun 7, 2026, 13:59Ghanim Ullah: Determining the Role of NCX1 in Neurons and Astrocytes During Ischemic Stroke
-
Jun 7, 2026, 13:51Billy Alexander: Learning from Volunteers as I Begin My Journey with the Stroke Association Scotland